Mayinglong Pharmaceutical Group Co Ltd600993
± Mixedrelevance
Management change with no stated impact on operations or financials.

Mayinglong announced on August 25 that Xia Youzhang resigned as general manager for personal reasons and will continue to serve as a director, a member of the strategy committee, and in management roles at subsidiaries. The board of directors simultaneously appointed Zhou Daonian as general manager. In the first half of 2026, Mayinglong achieved revenue of 2.012 billion yuan and net profit attributable to the parent of 363 million yuan.
Mayinglong Pharmaceutical Group Co LtdManagement change with no stated impact on operations or financials.